BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 1, 2011
View Archived Issues
Aliskiren/amlodipine combination shows promise as initial therapy for hypertension
Read More
Phase II data presented on sorafenib in GIST and esophageal/gastroesophageal junction cancer
Read More
Polypill reduces cardiovascular risk factors in clinical trial
Read More
Pfizer develops novel inhibitors of HCV replication
Read More
Novel beta-secretase 1 inhibitors claimed at Lilly
Read More
Neuropilin-2 promotes epithelial-mesenchymal transition in CRC
Read More
CFAK-C4 receives FDA orphan drug status in pancreatic cancer based on preclinical data
Read More
First-line TH-302 plus gemcitabine shows promise in advanced/metastatic pancreatic cancer
Read More
Receptos begins treatment in phase I trial of RPC-1063 for multiple sclerosis
Read More
ALS Biopharma receives ADDF grant to develop HSP70 inducers for AD
Read More
Apogenix provides update on phase II APG-101 trial in glioblastoma multiforme
Read More
New agents with antidepressant activity claimed by Green Cross
Read More
Primary efficacy endpoint met in phase III Gattex trial in short bowel syndrome
Read More
DigiFab approved in Canada to treat digoxin toxicity/overdose
Read More
New lysophospholipid S1P1 receptor agonists patented
Read More
Allergan and MAP Pharma collaborate on Levadex for acute migraine
Read More
Vivalis divulges new inhibitors of RNA-directed RNA polymerase
Read More
Provectus completes treatment in phase I trial of PV-10 in liver cancer
Read More
Nuedexta launched in U.S. for treatment of pseudobulbar affect
Read More
Phase I data reported on NRM-8499, a prodrug for Alzheimer's disease
Read More
Peregrine fully enrolls phase Ib trial of bavituximab in HIV/HCV coinfection
Read More
CHMP recommends approval of BF-200 ALA for actinic keratosis
Read More
Onyx initiates rolling NDA for carfilzomib in multiple myeloma
Read More
Manhattan Pharma to advance AST-915 to phase II in essential tremor
Read More
Phase III trial of Cytotect for prevention of congenital CMV infection to continue
Read More
Faron and Maruishi to collaborate on Traumakine program in Japan
Read More